IDP-023CD38-mAbProvidence Cancer InstituteWeill Medical College of Cornell Universitymultiple myelomaUniversity of MinnesotaAdvarraRRMMNEXT VirginiaSalus IRB
…ngoing; updated efficacy outcomes will be presented.Conclusions IDP-023 off-the-shelf allogeneic g-NK-cell therapy alone or in combinat…